Navigation Links
Launch of Fountain Healthcare Partners, a Life Science Venture Capital Firm
Date:4/29/2008


DUBLIN and NEW YORK, April 29 /PRNewswire/ --

- Announces First Close of EUR75 ($117) Million

- Largest Life Science Venture Capital ("VC") Fund Launched in Ireland

- One of the Largest Emerging Manager VC Funds Raised in the Life

Science Sector Globally

- Headquartered in Dublin, Fountain Will Invest the Majority of its

Capital in Europe With a Primary Focus on Ireland

Fountain Healthcare Partners ("Fountain") today launches and announces the first close of its inaugural fund, Fountain Healthcare Partners I, with EUR75 ($117) million of committed capital.

The fund is the largest dedicated life science (specialty pharmaceuticals, biotechnology, medical devices and diagnostics) venture capital ("VC") firm based in Ireland. It is also one of the largest emerging manager VC funds raised in the life science sector globally in the past 2 years.

Fountain will invest the majority of its capital in Europe and will have a strong emphasis on the life science sector in Ireland. The first close significantly exceeded initial expectations and Fountain is now targeting approximately EUR100 million in commitments at its final close.

Over 90% of the capital invested in the fund was sourced from institutional investors of which 75% are Irish based. Institutional investors include the European Investment Fund, the National Pension Reserve Fund and Enterprise Ireland. A select number of high net worth individual investors also participated. "We have been very pleased with the level and quality of investor participation in the first close. There was clear support for our investment strategy, and we significantly exceeded our original first close target," said Dr Manus Rogan, a founding partner at Fountain.

Fountain is a bi-located fund with a main office in Dublin and a second office in New York. "The purpose of our New York office is to maintain on-the-ground connectivity with the US life-scien
'/>"/>

SOURCE Fountain Healthcare Partners
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. More Than 700 Physicians and Administrators Participate in the Visian ICL Growth Program(TM) Launch
2. Pathwork(R) Diagnostics Launches Genomics-Based Test For Hard-To-Identify Tumors Through Its CLIA-Certified Laboratory
3. The Lustgarten Foundation for Pancreatic Cancer Research Launches New Public Service Announcement Featuring Last Lecturer Dr. Randy Pausch
4. Hovione Launches New Website
5. International Council on Nanotechnology launches global research needs assessment
6. Sigma(R) Launches Innovative ChIP Kit Technology For Epigenetic Research
7. Cypress Systems, Inc. Launches Cancer Prevention Health Campaign Using SelenoExcell(R)
8. Botaneco Announces Launch of Second Generation Oleosome Product
9. Novagali Pharma Announces the Launch of Cationorm(R)
10. Angiotech announces commercial launch of Cook Medicals Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
11. Cellix Ltd. Launches VenaEC Biochip for Flow-based Cell-adhesion Assays
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Chester, NJ (PRWEB) August 21, 2014 ... of personal selling optimization technology and services for ... publication of “Grading Pharma’s Use of New Commercial ... of Measurement & Analytics. , The article examines ... marketing yield that are being tested in the ...
(Date:8/21/2014)... August 21, 2014 SoundConnect ... been recognized as one of the nation’s Fastest ... magazine for the 2nd consecutive year. Inc. magazine ... annual Inc. 500|5000, an exclusive ranking of the ... most comprehensive look at the most important segment ...
(Date:8/20/2014)... analysis of patented university inventions licensed to biotechnology ... to commercialization. To open these roadblocks, the researchers ... during the discovery stage could lead to faster ... frequently derived from discoveries made in university laboratories ... known during clinical trials, which have a high ...
(Date:8/20/2014)... Fla. , Aug. 20, 2014 ... will host a conference call to provide an ... 2014Time:4:30 p.m. Eastern daylight timeDial-in numbers:(888) 505-4369 (U.S. ... 9126599 Live web cast: www.neurotropebioscience.com , under "Investor ... hours after completion through September 2, 2014 at ...
Breaking Biology Technology:Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2SoundConnect Returns on Inc. 5000 List of Fastest Growing Companies 2SoundConnect Returns on Inc. 5000 List of Fastest Growing Companies 3Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3Neurotrope To Host Conference Call 2
... Management and Patient,Safety Institute (RM&PSI) today announced its ... RM&PSI ( http://www.rmpsi.com ), a subsidiary of FinCor,Holdings ... in,clinical risk management and patient safety programs and ... The spring 2009 calendar also ...
... new white papers detailing sterility testing essentials are ... www.microtestlabs.com ). The white papers, one which ... which is specialized for pharmaceutical manufacturers, presents the ... and reviews different testing methodologies.For medical device manufacturers, ...
... NEOG ) has received approval from the ... its quick and easy BetaStar(R)US test,for dairy antibiotics in ... United States to use Neogen,s new test to comply ... for dairy antibiotics. , Neogen,s ...
Cached Biology Technology:The Risk Management and Patient Safety Institute Announces Winter and Spring 2009 Audio Program Lineup, Annual Conference Dates 2The Risk Management and Patient Safety Institute Announces Winter and Spring 2009 Audio Program Lineup, Annual Conference Dates 3Free White Papers Detail Sterility Testing Essentials for Medical Device, Pharmaceutical Manufacturers 2Neogen's BetaStar(R) US Dairy Antibiotic Test Approved by FDA/NCIMS 2
(Date:8/21/2014)... study of American singles found that during sex ... orgasm rates. On average, men experience orgasm 85.1 ... making little difference. For women, however, orgasm occurrence ... 62.9 percent of the time during sex with ... with women,s sexual orientation, with lesbian women experiencing ...
(Date:8/21/2014)... Aug. 21, 2014 /PRNewswire-iReach/ -- LiveScan Service ... agreed to a partnership with Gabriel Health Institute, ... fastest growing Certified Nursing Assistant preparatory schools. ...  an exclusive member of Binary,s LiveScan service provider,s ... will improve its service capabilities by widening ...
(Date:8/21/2014)... window? It consists of radiations in the 3.3 to ... water in biological tissues. New theoretical findings show that ... water window. These could be the basis of an ... biological samples or to be used in high-precision spectroscopy. ... needed to efficiently generate the harmonic radiationswhich are multiples ...
Breaking Biology News(10 mins):Orgasm rates for single women less predictable than men's, vary by sexual orientation 2Orgasm rates for single women less predictable than men's, vary by sexual orientation 3Orgasm rates for single women less predictable than men's, vary by sexual orientation 4LiveScan Provider Binary Biometrics Announces Partnership with Preeminent CNA School, Gabriel Health Institute to Expand Services in Orlando Region 2LiveScan Provider Binary Biometrics Announces Partnership with Preeminent CNA School, Gabriel Health Institute to Expand Services in Orlando Region 3Water window imaging opportunity 2
... to each person or set of identical twins. That ... crime detection to international travel. But what happens when ... patterns of ridges? It,s not the premise ... known as adermatoglyphia. It,s also known as "Immigration Delay ...
... on the detrimental impact of some common medicines on elderly people ... a few of these medicines does not appear to cause further ... In a paper published today by the journal ... East Anglia (UEA) and colleagues from a number of other universities ...
... - The first fluorescence-guided surgery on an ovarian cancer patient ... agent created by a Purdue University researcher. The surgery ... phase of a clinical trial to evaluate a new technology ... ovarian cancer patients. The method illuminates cancer cells to help ...
Cached Biology News:Shake hands with the invisible man 2Reassurance for dementia sufferers on impact of common drugs 2Purdue technology used in first fluorescence-guided ovarian cancer surgery 2Purdue technology used in first fluorescence-guided ovarian cancer surgery 3Purdue technology used in first fluorescence-guided ovarian cancer surgery 4
Mouse monoclonal [0.N.509] to PCTAIRE2 ( Abpromise for all tested applications). entrezGeneID: 5128 SwissProtID: Q00537...
MMP-2 / MMP-9 Inhibitor IV is a potent, selective, slow binding and mechanism based inhibitor of human gelatinases. • Molecular weight: 306.4 • Molecular Formula: C(15)H(14)O(3)S(2). &bul...
... Zeba Desalt Spin Columns contain a proprietary ... offers exceptional desalting and protein-recovery characteristics compared ... as low as 25 g/ml of protein ... and > 95% retention of salts and ...
Rabbit polyclonal to GABA A Receptor gamma 2 ( Abpromise for all tested applications). entrezGeneID: 2566 SwissProtID: P18507...
Biology Products: